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Abstract: Transaminases are valuable enzymes for industrial 
biocatalysis that enable the preparation of optically pure amines. For 
these transformations they require either an amine donor (amination 
of ketones) or an amine acceptor (deamination of racemic amines). 
In this work transaminases are shown to react with aromatic β-
fluoroamines, leading to simultaneous enantioselective 
dehalogenation and deamination to form the corresponding 
acetophenone derivatives in the absence of an amine acceptor. A 
series of racemic β-fluoroamines was resolved in a kinetic resolution 
via tandem hydrodefluorination-deamination, giving the 
corresponding amines with up to >99% ee. This is a first example of 
exploiting the catalytic promiscuity of transaminases as a tool for 
novel transformations. 
In recent years, many enzymes have been shown to efficiently 
catalyze transformations that appear far removed from their 
natural activity. This catalytic promiscuity[1] can be useful for 
synthetic purposes, broadening the applicability of biocatalysts. 
While many examples have recently been described for 
hydrolases,[2] the application of these unconventional processes 
for other enzyme classes has not been fully developed.[3] Among 
biocatalysts that have demonstrated broad applicability, 
transaminases (TAs) can be highlighted, as they perform the 
amination of an amine acceptor (ketone or aldehyde) using an 
amine donor (e.g., alanine or isopropylamine, Scheme 1a), 
mediated by the cofactor pyridoxal 5’-phosphate (PLP).[4,5] 
Interestingly, transaminases can also catalyze the reverse 
reaction, achieving the kinetic resolution of racemic amines via 
amination of an amine acceptor (e.g., pyruvate or acetone, 
Scheme 1b). This process is hampered by the disadvantage of a 
maximum of 50% yield, but it is thermodynamically favored in 
comparison to the amination route.[4,6] 
 
Scheme 1. Methodologies to obtain enantiopure amines using TAs by: a) 
amination of a carbonyl compound using an amine donor; b) deamination of a 
racemic amine employing an amine acceptor; and c) novel tandem 
hydrodefluorination-deamination kinetic resolution of racemic β-fluoroamines. 
The introduction of fluorine atom(s) to an organic derivative 
has a significant influence on, e.g. their physicochemical, 
conformational and metabolic properties.[7] The cleavage of a 
C−F into a C−H bond, hydrodefluorination,[8] has been 
performed in the case of aromatic derivatives using transition 
metal complexes under harsh reaction conditions. For aliphatic 
fluorinated compounds however, alternatives still remain to be 
found,[9] partly due to the inertness of C−F bonds.[10] β-
Fluoroamines are potent inhibitors of PLP-dependent enzymes 
such as aminotransferases and decarboxylases.[11] These 
proteins are crucial in living organisms and are therefore 
commonly envisaged as therapeutic targets.[12] Silverman and 
co-workers demonstrated that 4-amino-5-fluoropentanoic acid 
was an irreversible inhibitor of γ-aminobutyrate 
aminotransferase (GABA-AT).[13] 
Herein we show that a promiscuous reactivity of 
transaminases can be applied to obtain a series of enantiopure 
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β-fluoroamines by unprecedented formal tandem 
hydrodefluorination-deamination kinetic resolution, starting from 
the racemic β-fluoroamines, in the absence of an amine 
acceptor, under simple and mild conditions in aqueous medium 
(Scheme 1c). Thus, it was exploited that the inhibition of certain 
transaminases by β-fluoroamines is negligible under the reaction 
conditions employed. 
Table 1. Enzymatic transformations on β-fluoroamine 1a.
[a]
  
 
Entry Enzymatic preparation 1a [%]
[b]
 2a [%]
[b]
 3a [%]
[b]
 
1 -- >99 <1 <1 
2 ATA-231
[c]
 41 <1 59 
3 TA-P1-F03
[c]
 53 <1 47 
4 TA-P1-G06
[c]
 28 <1 72 
5 BSA >99 <1 <1 
6 CAL-B >99 <1 <1 
7 Lyo. E. coli >99 <1 <1 
[a] For reaction conditions, see Supporting Information. [b] Measured by GC 
analysis. [c] Transaminase commercially available from Codexis company. 
To study the reactivity of TAs with fluorinated 
compounds,[5c,14] we focused on the most thermodynamically 
favored reaction conditions using β-fluoroamine 1a and acetone 
as amine acceptor, in order to obtain the corresponding 
enantioenriched amine 1a, together with α-fluoro ketone 2a 
under typical kinetic resolution conditions (Scheme 1b). Several 
commercially available TAs did not afford this product but 
acetophenone 3a to a high extent (data not shown). Furthermore, 
similar conversions were attained in the absence of the amine 
acceptor (Table 1), with only the dehalogenated ketone 3a 
detected as a product (entries 2-4). Since the substrate was 
stable in the blank reaction (entry 1), and in the presence of 
other enzymatic or protein preparations such as bovine serine 
albumin (BSA), lipase B from Candida antarctica (CAL-B) and 
lyophilized cells of E. coli (entries 5-7), it was clear that this 
amine was transformed by the tested TAs, resulting in both 
hydrodefluorination and deamination reactions. 
Further experiments also demonstrated that this 
transformation may occur in hand with enzymatic deactivation, 
as in the presence of fluorinated substrates, selected TAs lost 
their activity at least partially (see Supporting Information for 
more details). Our next objective was the proposal of a plausible 
mechanism that could explain these results. Based on the work 
by Silverman and co-workers on GABA-AT inhibitors,[14] and with 
reference to his previous mechanistic studies,[15,16] we suggest a 
dual mechanism for defluorination and inhibition (Scheme 2). 
 
 
Scheme 2. Proposed dehalogenation (route a) and inhibition (route b) mechanisms catalyzed by TAs employing β-fluoroamine 1a. 
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As a first step, PLP, which is linked to the catalytic lysine of 
the TA,[17] is transferred to the reacting amine 1a forming the 
external aldimine intermediate. Then, it rearranges into the 
ketimine intermediate, which is converted into the 
dehalogenated aldimine I due to the presence of the fluorine 
atom at the α-position acting as a leaving group. Then, the 
catalytic lysine can attack the imine bond generating the internal 
aldimine together with an enamine derivative. At this stage, two 
different pathways can occur. If the enamine quickly diffuses into 
the reaction medium (route a), it will be hydrolyzed affording the 
defluorinated ketone (in this case 3a), and the enzyme will be 
able to start a new catalytic cycle, therefore not having been 
inactivated. However, if the enamine remains in the active site of 
the enzyme for a sufficient time (route b), it will attack the 
internal aldimine created by PLP and the catalytic lysine, thus 
providing an imine which, after hydrolysis, will furnish a final 
covalent adduct (II) inactivating the transaminase irreversibly. 
Moreover, the proposed mechanism can explain the reason why 
an amine acceptor is not necessary, as the transfer of an amine 
group does not occur, rather it is a simple hydrolysis of an imine 
bond releasing an ammonia molecule. 
Table 2. Tandem hydrodefluorination-deamination kinetic resolution of β-
fluoroamines 1a-f.
[a]
 
 
Entry Substrate CV-TA ArR-TA 
  3a-f [%]
[b]
 ee 1a-f 
[%]
[c,d]
 
3a-f [%]
[b]
 ee 1a-f 
[%]
[c,d]
 
1 1a 53 99 (S) 22 23 (R) 
2 1b 50 99 (S) 67 >99 (R) 
3 1c 52 >99 (S) 51 >99 (R) 
4 1d 51 >99 (S) 28 40 (R) 
5 1e 60 >99 (S) 54 >99 (R) 
6 1f 55 99 (S) 55 >99 (R) 
[a] For reaction conditions, see Supporting Information. [b] Measured by GC 
analysis. [c] Measured by chiral GC analysis. [d] Change in Cahn-Ingold-
Prelog (CIP) priority. 
Then, it was investigated if this reaction could be performed 
enantioselectively. Ideally, a kinetic resolution via tandem 
hydrodefluorination-deamination could be achieved (Scheme 1c). 
A series of transaminases overexpressed in E. coli was 
employed: the S-selective TA from Chromobacterium violaceum 
(CV-TA),[18] S- and R-selective TAs from Arthrobacter sp. (ArS-
TA[19] and ArR-TA,[20] respectively), and a variant of the ArR-TA 
with mutations in 27 positions (ArRmut11-TA),[5c] which is also 
R-selective. These TAs have displayed excellent activities for 
aromatic substrates, providing the corresponding amines with 
high selectivities.[21] A set of racemic aromatic β-fluoroamines 
(1a-f) was purchased or synthesized as described in the SI.[22] 
We used lyophilized preparations of E. coli cells due to their 
easy handling and high stability.[21c,d] After a first enzymatic 
screen (see SI), we obtained the best results for CV-TA and 
ArR-TA, resulting in excellent resolutions for most of the 
substrates (Table 2). Thus, different derivatives, including those 
with electron-donating or withdrawing groups at the phenyl 
moiety, were obtained with high enantiomeric excess. Moreover, 
depending on the transaminase used, both enantiomers were 
attained either in optically pure form or at least optically enriched. 
Thus, CV-TA reacted preferentially with the (R)-antipode and 
ArR-TA with the (S)-enantiomer. 
Finally, we applied this transformation concept on a 
preparative scale. Thus, 100 mg of racemic amines 1a and 1d 
were resolved using CV-TA into the corresponding (S)-
derivatives (>99% ee) within 32 h, and with 75-80% yield of 
isolated product after a simple extraction protocol (see SI). 
In order to obtain evidence of the mechanism of inhibition 
proposed in Scheme 2, the X-ray crystal structure of ArRmut11-
TA was obtained from protein that had been pre-incubated with 
amine 1d. Details of the structure can be found in the Supporting 
Information. Following building and refinement of protein and 
water atoms, clear electron density was observed in the omit 
map at the interface of six dimer pairs for PLP (corresponding to 
twelve PLP sites). Two regions of continuous electron density 
projected from the electrophilic carbon of PLP: the first 
connecting the PLP to the side-chain of Lys188, and the second 
extending from the PLP into the active site. This density (Figure 
1) was successfully modelled as the adduct resulting from 
inhibition of the enzyme by 1d, representing structure II in 
Scheme 2. 
 
Figure 1. Active site at the dimer interface of ArRmut11-TA inhibited by 
complexation with 1d and showing PLP covalently bonded to both K188 and 
the residual ligand, representing complex II as shown in Scheme 2. Backbone 
and C-atoms of subunit ‘A’ are shown in light blue. PLP adduct is shown in 
ball-and-stick format with carbon atoms in grey and the bromine atom in green. 
Electron density maps correspond to the Fo-Fc omit map and the 2Fo-Fc map in 
blue and red, and at levels of 3 and 1 respectively. The omit map is that 
obtained prior to modelling and refinement of the ligand. 
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In summary, we have reported a novel enantioselective 
transformation based on a promiscuous activity of 
transaminases, namely a tandem hydrodefluorination-
deamination reaction in aqueous medium under very mild 
conditions. This process was demonstrated for the kinetic 
resolution of racemic β-fluoroamines to obtain the non-converted 
amines with excellent ee. Remarkably no amine acceptor such 
as, e.g. acetone, was necessary. Depending on the biocatalyst 
of choice, both enantiomers could be obtained. 
Hydrodefluorination is an interesting reaction that has been 
studied during recent years.[8] The use of metal complexes has 
allowed the cleavage of aromatic C‒F bonds, but methods to 
cleave aliphatic bonds are not accessible. The proposed 
biocatalytic concept expands the toolkit for asymmetric synthesis 
complementing previous chemical processes, and illustrates the 
potential of catalytic promiscuity as a tool for designing 
unprecedented reactions. 
Acknowledgements 
A.C. thanks the Principado de Asturias for his postdoctoral 
fellowship Clarín. E.-M. Fischereder acknowledges the 
European Union’s 7th framework program FP7/2007-2013 under 
grant agreement #289646 (KyroBio). Financial support from 
MICINN (Project CTQ2013-44153-P) is gratefully acknowledged. 
Keywords: transamination • catalytic promiscuity • biocatalysis • 
kinetic resolution • hydrodefluorination 
[1] a) U. T. Bornscheuer, R. J. Kazlauskas in Enzyme Catalysis in Organic 
Synthesis, 3
rd
 Ed., (Eds.: K. Drauz, H. Gröger, O. May), Wiley-VCH, 
Weinheim, 2012, pp. 1695–1733; b) R. J. Kazlauskas, U. T. 
Bornscheuer in Comprehensive Chirality, Vol. 7 (Eds.: E. M. Carreira, H. 
Yamamoto), Elsevier, Amsterdam, 2012, pp. 465–480; c) M. S. Humble, 
P. Berglund, Eur. J. Org. Chem. 2011, 3391–3401; d) K. Hult, P. 
Berglund, Trends Biotechnol. 2007, 25, 232–238; e) R. J. Kazlauskas, 
Curr. Opin. Chem. Biol. 2005, 9, 195–201. 
[2] E. Busto, V. Gotor-Fernández, V. Gotor, Chem. Soc. Rev. 2010, 39, 
4504–4523. 
[3] Recent examples: a) P. S. Coelho, E. M. Brustad, A. Kannan, F. H. 
Arnold, Science 2013, 339, 307–310; b) P. S. Coelho, Z. J. Wang, M. E. 
Ener, S. A. Baril, A. Kannan, F. H. Arnold, E. M. Brustad, Nat. Chem. 
Biol. 2013, 9, 485–487; c) B.-J. Baas, E. Zandvoort, E. M. Geertsema, 
G. J. Poelarends, ChemBioChem 2013, 14, 917–926; d) G.-D. Roiban, 
M. T. Reetz, Angew. Chem. 2013, 125, 5549–5550; Angew. Chem. Int. 
Ed. 2013, 52, 5439–5440; (e) S. C. Hammer, P.-O. Syren, M. Seitz, B. 
M. Nestl, B. Hauer, Curr. Opin. Chem. Biol. 2013, 17, 293–300. 
[4] a) R. C. Simon, E. Busto, E.-M. Fischereder, C. S. Fuchs, D. Pressnitz, 
N. Richter, W. Kroutil in Science of Synthesis, Biocatalysis in Organic 
Synthesis, (Eds.: K. Faber, W.-D. Fessner, N. J. Turner), Georg Thieme 
Verlag, Stuttgart, 2015, pp. 383‒420; b) R. C. Simon, N. Richter, E. 
Busto, W. Kroutil, ACS Catal. 2014, 4, 129‒143; c) M. Höhne, U. T. 
Bornscheuer in Enzyme Catalysis in Organic Synthesis, 3
rd
 Ed., (Eds.: 
K. Drauz, H. Gröger, O. May), Wiley-VCH, Weinheim, 2012, pp. 779‒
820; d) M. S. Malik, E.-S. Park, J.-S. Shin, Appl. Microbiol. Biotechnol. 
2012, 94, 1163‒1171; e) S. Mathew, H. Yun, ACS Catal. 2012, 2, 993‒
1001; f) D. Koszelewski, K. Tauber, K. Faber, W. Kroutil, Trends 
Biotechnol. 2010, 28, 324‒332; g) H. C. Hailes, P. A. Dalby, G. J. Lye, 
F. Baganz, M. Micheletti, N. Szita, J. M. Ward, Curr. Org. Chem. 2010, 
14, 1883‒1893; h) D. Zhu, L. Hua, Biotechnol. J. 2009, 4, 1420‒1431. 
[5] a) M. Fuchs, J. E. Farnberger, W. Kroutil, Eur. J. Org. Chem. 2015, 
6965‒6982; b) Z. Peng, J. W. Wong, E. C. Hansen, A. L. A. Puchlopek-
Dermenci, H. J. Clarke, Org. Lett. 2014, 16, 860‒863; c) C. K. Savile, J. 
M. Janey, E. C. Mundorff, J. C. Moore, S. Tam, W. R. Jarvis, J. C. 
Colbeck, A. Krebber, F. J. Fleitz, J. Branz, P. N. Devine, G. W. 
Huisman, G. J. Hughes, Science 2010, 329, 305‒309. 
[6] a) P. Tufvesson, J. S. Jensen, W. Kroutil, J. M. Woodley, Biotechnol. 
Bioeng. 2012, 109, 2159‒2162; b) J.-S. Shin, B.-G. Kim, Biotechnol. 
Bioeng. 1998, 60, 534–540. 
[7] S. Purser, P. R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 
2008, 37, 320‒330. 
[8] M. K. Whittlesey, E. Peris, ACS Catal. 2014, 4, 3152–3159. 
[9] Other enzymes such as engineered glycosidases have shown 
glycosynthase activity catalyzing transglycosylation reactions of 
glycosyl fluoride donors by nucleophilic substitution of the fluorine atom. 
See, for instance: a) T. Pozzo, M. Plaza, J. Romero-García, M. Faijes, 
E. N. Karlsson, A. Planas, J. Mol. Catal. B: Enzym. 2014, 107, 132–
139; b) D. H. Kwan, S. G. Withers, J. Carbohydr. Chem. 2011, 30, 181–
205; c) R. Kittl, S. G. Withers, Carbohydr. Res. 2010, 345, 1272–1279. 
[10] a) M. Ahrens, G. Scholz, T. Braun, E. Kemnitz, Angew. Chem. 2013, 
125, 5436–5440; Angew. Chem. Int. Ed. 2013, 52, 5328–5332; b) C. 
Douvris, O. V. Ozerov, Science 2008, 321, 1188–1190. 
[11] S. M. Nanavati, R. B. Silverman, J. Med. Chem. 1989, 32, 2413‒2421. 
[12] A. Amadasi, M. Bertoldi, R. Contestabile, S. Bettati, B. Cellini, M. L. di 
Salvo, C. Borri-Voltattorni, F. Bossa, A. Mozzarelli, Curr. Med. Chem. 
2007, 14, 1291‒1324. 
[13] a) R. B. Silverman, M. A. Levy, Biochemistry 1981, 20, 1197‒1203; b) 
R. B. Silverman, M. A. Levy, J. Org. Chem. 1980, 45, 815‒818. 
[14] Although not widely implemented, the application of TAs to the 
production of fluorinated amines can be envisaged as a promising tool 
to gain access to these derivatives under mild reaction conditions. See: 
M. D. Truppo, H. Strotmann, G. Hughes, ChemCatChem 2012, 4, 
1071–1074. 
[15] R. B. Silverman, B. J. Invergo, Biochemistry 1986, 25, 6817–6820. 
[16] P. Storici, J. Qiu, T. Schirmer, R. B. Silverman, Biochemistry 2004, 43, 
14057–14063. 
[17] a) H. Mizuguchi, H. Hayashi, K. Okada, I. Miyahara, K. Hirotsu, H. 
Kagamiyama, Biochemistry 2001, 40, 353–360; b) J. M. Goldberg, J. F. 
Kirsh, Biochemistry 1996, 35, 5280–5291. 
[18] U. Kaulmann, K. Smithies, M. E. B. Smith, H. C. Hailes, J. M. Ward, 
Enzyme Microb. Technol. 2007, 41, 628–637. 
[19] S. Pannuri, S. V. Kamat, A. R. M. Garcia, (Cambrex North Brunswick 
Inc.) WO 2006/063336A2, 2006. 
[20] A. Iwasaki, Y. Yamada, Y. Ikenaka, J. Hasegawa, Biotechnol. Lett. 
2003, 25, 1843–1846. 
[21] Examples: a) D. Pressnitz, C. S. Fuchs, J. H. Sattler, T. Knaus, P. 
Macheroux, F. G. Mutti, W. Kroutil, ACS Catal. 2013, 3, 555–559; b) F. 
G. Mutti, W. Kroutil, Adv. Synth. Catal. 2012, 354, 3409–3413; c) F. G. 
Mutti, C. S. Fuchs, D. Pressnitz, J. H. Sattler, W. Kroutil, Adv. Synth. 
Catal. 2011, 353, 3227–3233; d) D. Koszelewski, M. Goeritzer, D. Clay, 
B. Seisser, W. Kroutil, ChemCatChem 2010, 2, 73–77. 
[22] a) W. Borzęcka, I. Lavandera, V. Gotor, J. Org. Chem. 2013, 78, 7312–
7317; b) C. Zizhan, W. Zhu, Z. Zheng, X. Zou, J. Fluorine Chem. 2010, 
131, 340–344. 
 
COMMUNICATION          
 
 
 
 
 
Entry for the Table of Contents 
 
COMMUNICATION 
Text for Table of Contents 
 
Aníbal Cuetos, Marina García-Ramos, 
Eva-Maria Fischereder, Alba Díaz-
Rodríguez, Gideon Grogan, Vicente 
Gotor,* Wolfgang Kroutil,* and Iván 
Lavandera* 
Page No. – Page No. 
Catalytic Promiscuity of 
Transaminases: Preparation of 
Enantioenriched β-Fluoroamines via 
Formal Tandem Hydrodefluorination-
Deamination 
 
 
 
 
 
